Although it has been accepted for decades that women with gestational diabetes mellitus (GDM) are at high risk for future development of type 2 diabetes, vigorous debate regarding the value of detecting and treating GDM has persisted into the twenty-first century. Although results from 2 randomized trials provide strong evidence that treating GDM reduces adverse perinatal outcomes, it remains to be determined whether treatment impacts long-term offspring outcomes. Insulin is the first-line pharmacologic treatment and is added when glycemic goals are not met with nutritional modifications. Oral agent use is controversial, as data on long-term offspring outcomes are lacking.
|Original language||English (US)|
|Number of pages||15|
|Journal||Endocrinology and Metabolism Clinics of North America|
|State||Published - Sep 2019|
- Gestational diabetes mellitus
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism